BDNF rs6265 polymorphism and drug addiction: A systematic review and meta-analysis

Pharmacogenomics

Volumn 14, Issue 16, 2013, Pages 2055-2065

  Haerian, Batoul Sadat ^a  

^a UNIVERSITY OF MALAYA   (Malaysia)

Author keywords

addiction; BDNF; polymorphism; susceptibility

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR;

ALCOHOLISM; ALLELE; BDNF GENE; CHINESE; DRUG DEPENDENCE; GENETIC ASSOCIATION; GENETIC POLYMORPHISM; GENETIC RISK; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEROIN DEPENDENCE; HUMAN; METHAMPHETAMINE DEPENDENCE; REVIEW; RISK FACTOR; SUBSTANCE ABUSE; SYSTEMATIC REVIEW; TOBACCO DEPENDENCE;

ALCOHOLS; ASIAN CONTINENTAL ANCESTRY GROUP; BRAIN-DERIVED NEUROTROPHIC FACTOR; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HEROIN; HEROIN DEPENDENCE; HUMANS; METHAMPHETAMINE; POLYMORPHISM, GENETIC; SUBSTANCE-RELATED DISORDERS;

EID: 84889009041     PISSN: 14622416     EISSN: 17448042     Source Type: Journal    
DOI: 10.2217/pgs.13.217     Document Type: Review

References (53)

1. WHO. International Statistical Classification of Diseases and Related Problems (10th Edition). WHO Press, Switzerland (1992).
2. Koob GF, Le Moal M. Drug abuse: hedonic homeostatic dysregulation. Science 278(5335), 52-58 (1997).
3. Nestler EJ, Aghajanian GK. Molecular and cellular basis of addiction. Science 278(5335), 58-83 (1997).
4. Duman RS, Monteggia LM. A neurotrophic model for stress-related mood disorders. Biol. Psychiatry 59(12), 1116-1127 (2006).
5. Reichardt LF. Neurotrophin-regulated signalling pathways. Philos. Trans. R. Soc. Lond. B Biol. Sci. 361(1473), 1545-1564 (2006).
6. Goldstein DB, Cavalleri GL. Genomics: understanding human diversity. Nature 437(7063), 1241-1242 (2005).
7. Wang L, McLeod HL, Weinshilboum RM. Genomics and drug response. N. Engl. J. Med. 364(12), 1144-1153 (2011).
8. Guillin O, Diaz J, Carroll P et al. BDNF controls dopamine D3 receptor expression and triggers behavioural sensitization. Nature 411(6833), 86-89 (2001).
9. Ikeda T, Tamura N, Matsuki N et al. Conserved role of brain-derived neurotrophic factor in Val66Met: target-selective reinforcement of GABAergic synapses. Neuroreport 17(18), 1847-1851 (2006).
10. Fritsch B, Reis J, Martinowich K et al. Direct current stimulation promotes BDNF-dependent synaptic plasticity: potential implications for motor learning. Neuron 66(2), 198-204 (2010).
11. Cheng CY, Hong CJ, Yu YW et al. Brain-derived neurotrophic factor (Val66Met) genetic polymorphism is associated with substance abuse in males. Brain Res. Mol. Brain Res. 140(1-2), 86-90 (2005).
12. Itoh K, Hashimoto K, Shimizu E et al. Association study between brain-derived neurotrophic factor gene polymorphisms and methamphetamine abusers in Japan. Am. J. Med. Genet. B Neuropsychiatr. Genet. 132B(1), 70-73 (2005).
13. Tsai SJ, Liao DL, Yu YW et al. A study of the association of (Val66Met) polymorphism in the brain-derived neurotrophic factor gene with alcohol dependence and extreme violence in Chinese males. Neurosci. Lett. 381(3), 340-343 (2005).
14. Lang UE, Sander T, Lohoff FW et al. Association of the Met66 allele of brain-derived neurotrophic factor (BDNF) with smoking. Psychopharmacology (Berl.) 190(4), 433-439 (2007).
15. Montag C, Basten U, Stelzel C et al. The BDNF Val66Met polymorphism and smoking. Neurosci. Lett. 442(1), 30-33 (2008).
16. Bousman CA, Glatt SJ, Cherner M et al. Preliminary evidence of ethnic divergence in associations of putative genetic variants for methamphetamine dependence. Psychiatry Res. 178(2), 295-298 (2010).
17. Sim MS, Mohamed Z, Hatim A et al. Association of brain-derived neurotrophic factor (Val66Met) genetic polymorphism with methamphetamine dependence in a Malaysian population. Brain Res. 1357, 91-96 (2010).
18. Grzywacz A, Samochowiec A, Ciechanowicz A et al. Family-based study of brain-derived neurotrophic factor (BDNF) gene polymorphism in alcohol dependence. Pharmacol. Rep. 62(5), 938-941 (2010).
19. Jia W, Shi JG, Wu B et al. Polymorphisms of brain-derived neurotrophic factor associated with heroin dependence. Neurosci. Lett. 495(3), 221-224 (2011).
20. Matsushita S, Kimura M, Miyakawa T et al. Association study of brain-derived neurotrophic factor gene polymorphism and alcoholism. Alcohol. Clin. Exp. Res. 28(11), 1609-1612 (2004).
21. Muschler MA, Heberlein A, Frieling H et al. Brain-derived neurotrophic factor, Val66Met single nucleotide polymorphism is not associated with alcohol dependence. Psychiatr. Genet. 21(1), 53-54 (2011).
22. Serý O, St'astný F, Zvolský P et al. Association between Val66Met polymorphism of brain-derived neurotrophic factor (BDNF) gene and a deficiency of colour vision in alcohol-dependent male patients. Neurosci. Lett. 499(3), 154-157 (2011).
23. Su N, Zhang L, Fei F et al. The brain-derived neurotrophic factor is associated with alcohol dependence-related depression and antidepressant response. Brain Res. 1415, 119-126 (2011).
24. Al-Eitan LN, Jaradat SA, Hulse GK et al. Custom genotyping for substance addiction susceptibility genes in Jordanians of Arab descent. BMC Res. Notes 5, 497 (2012).
25. Meng C, Lan J, Wang Y et al. Influence of brain-derived neurotrophic factor genetic polymorphisms on the ages of onset for heroin dependence in a Chinese population. Genet. Test. Mol. Biomarkers 16(9), 1044-1050 (2012).
26. Zhang XY, Chen da C, Xiu MH et al. BDNF Val66Met variant and smoking in a Chinese population. PLoS ONE 7(12), e53295 (2012).
27. Benzerouk F, Gierski F, Gorwood P et al. Brain-derived neurotrophic factor (BDNF) Val66Met polymorphism and its implication in executive functions in adult offspring of alcohol-dependent probands. Alcohol 47(4), 271-274 (2013).
28. Biskupska J, Borowiak KS, Karlin-Grazewicz K et al. Estimation of BDNF gene polymorphism and predisposition to dependence development for selected psychoactive compounds: genetic aspects of addiction with the selected drugs, amphetamine, tetrahydrocannabinol and opiates. Hum. Exp. Toxicol. 32(3), 236-240 (2013).
29. Lee SY, Wang TY, Chen SL et al. Interaction between novelty seeking and the aldehyde dehydrogenase 2 gene in heroin-dependent patients. J. Clin. Psychopharmacol. 33(3), 386-390 (2013).
30. Nedic G, Perkovic MN, Sviglin KN et al. Brain-derived neurotrophic factor Val66Met polymorphism and alcohol-related phenotypes. Prog. Neuropsychopharmacol. Biol. Psychiatry 40, 193-198 (2013).
31. Swartz MK. The PRISMA statement: a guideline for systematic reviews and meta-analyses. J. Pediatr. Health Care 25, 1-2 (2011).
32. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders (5th Edition). American Psychiatric Publishing, VA, USA (2013).
33. Bax L, Yu LM, Ikeda N et al. Development and validation of MIX: comprehensive free software for meta-analysis of causal research data. BMC Med. Res. Methodol. 6, 50 (2006).
34. Raivio N, Tiraboschi E, Saarikoski ST et al. Brain-derived neurotrophic factor expression after acute administration of ethanol. Eur. J. Pharmacol. 687(1-3), 9-13 (2012).
35. Sadri-Vakili G, Kumaresan V, Schmidt HD et al. Cocaine-induced chromatin remodeling increases brain-derived neurotrophic factor transcription in the rat medial prefrontal cortex, which alters the reinforcing efficacy of cocaine. J. Neurosci. 30(35), 11735-11744 (2010).
36. Vargas-Perez H, Ting-A Kee R, Walton CH et al. Ventral tegmental area: BDNF induces an opiate-dependent-like reward state in naive rats. Science 324(5935), 1732-1734 (2009).
37. Egan MF, Kojima M, Callicott JH et al. The BDNF Val66Met polymorphism affects activity-dependent secretion of BDNF and human memory and hippocampal function. Cell 112(2), 257-269 (2003).
38. Kambeitz JP, Bhattacharyya S, Kambeitz-Ilankovic LM et al. Effect of BDNF Val(66) Met polymorphism on declarative memory and its neural substrate: a meta-analysis. Neurosci. Biobehav. Rev. 36(9), 2165-2177 (2012).
39. Niitsu T, Fabbri C, Bentini F et al. Pharmacogenetics in major depression: a comprehensive meta-analysis. Prog. Neuropsychopharmacol. Biol. Psychiatry 45, 183-194 (2013).
40. Pei Y, Smith AK, Wang Y et al. The brain-derived neurotrophic-factor (BDNF) Val66Met polymorphism is associated with geriatric depression: a meta-analysis. Am. J. Med. Genet. B Neuropsychiatr. Genet. 159B(5), 560-566 (2012).
41. Wen W, Cho YS, Zheng W et al. Meta-analysis identifies common variants associated with body mass index in east Asians. Nat. Genet. 44(3), 307-311 (2012).
42. Chen ZY, Patel PD, Sant G et al. Variant brain-derived neurotrophic factor (BDNF) (Met66) alters the intracellular trafficking and activity-dependent secretion of wild-type BDNF in neurosecretory cells and cortical neurons. J. Neurosci. 24, 4401-4411 (2004).
43. Chen ZY, Ieraci A, Teng H et al. Sortilin controls intracellular sorting of brain-derived neurotrophic factor to the regulated secretory pathway. J. Neurosci. 25, 6156-6166 (2005).
44. Neves-Pereira M, Mundo E, Muglia P et al. The brain-derived neurotrophic factor gene confers susceptibility to bipolar disorder: evidence from a family-based association study. Am. J. Hum. Genet. 71, 651-655 (2002).
45. Brunoni AR, Lopes M, Fregni F. A systematic review and meta-analysis of clinical studies on major depression and BDNF levels: implications for the role of neuroplasticity in depression. Int. J. Neuropsychopharmacol. 11(8), 1169-1180 (2008).
46. Momose Y, Murata M, Kobayashi K et al. Association studies of multiple candidate genes for Parkinson's disease using single nucleotide polymorphisms. Ann. Neurol. 51, 133-136 (2002).
47. Tishkoff SA, Verrelli BC. Patterns of human genetic diversity: implications for human evolutionary history and disease. Annu. Rev. Genomics Hum. Genet. 4, 293-340 (2003).
48. Sabeti PC, Schaffner SF, Fry B et al. Positive natural selection in the human lineage. Science 312(5780), 1614-1620 (2006).
49. Dupont WD, Plummer WD. Power and sample size calculations for studies involving linear regression. Control. Clin. Trials 19(6), 589-601 (1998).
50. Spencer CC, Su Z, Donnelly P et al. Designing genome-wide association studies: sample size, power, imputation, and the choice of genotyping chip. PLoS Genet. 5, e1000477 (2009).
51. Dequeker E, Ramsden S, Grody WW et al. Quality control in molecular genetic testing. Nat. Rev. Genet. 2, 717-723 (2001).
52. Krasnova IN, Chiflikyan M, Justinova Z et al. CREB phosphorylation regulates striatal transcriptional responses in the self-administration model of methamphetamine addiction in the rat. Neurobiol. Dis. 58, 132-143 (2013).
53. Autry AE, Monteggia LM. Brain-derived neurotrophic factor and neuropsychiatric disorders. Pharmacol. Rev. 64(2), 238-258 (2012).